🇺🇸 FDA
Pipeline program

SECRET-HF: Treatment of Non-ischemic Dilated Cardiomyopathies by Intravenous Infusions of the Extracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells

APHP200034

Phase 1 other active

Quick answer

SECRET-HF: Treatment of Non-ischemic Dilated Cardiomyopathies by Intravenous Infusions of the Extracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells for Non-ischemic Dilated Cardiomyopathies is a Phase 1 program (other) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Non-ischemic Dilated Cardiomyopathies
Phase
Phase 1
Modality
other
Status
active

Clinical trials